ajtj's Post-Lobotomy Market Charts and Thoughts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Sun Tzu who wrote (42553)	11/10/2021 4:24:06 AM
From: Snowshoe	1 Recommendation Recommended By ajtj99 Read Replies (1) of 97426

re <<I thought they were buying Pfizer's?>> Merck announced its successful covid antiviral pill trial in early October, so Pfizer is about 30 days behind in the race. Apparently the US government has placed initial and followup orders Merck, and just an initial order with Pfizer. Each company needs an emergency use authorization (EUA) before its drug can be prescribed. Merck has already submitted its EUA application, and the FDA has scheduled a November 30th meeting to discuss it. Pfizer has announced it will submit its EUA application before Thanksgiving. In the meantime, we can expect frequent news flow as the companies work through the EUA process, book orders, ramp up pill production, and complete their other ongoing trials. In addition there are other companies working on this, so another competitor could stir things up. Pfizer had much better results than Merck in the recent round of trials, so I'm betting that Pfizer will eventually dominate this market.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next